Analyst Stock Ratings Initiations

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

Premium Tools & Ideas

Recent Analyst Stock Rating Initiation News

Select Energy Services Is Trading At Meaningful Discount To Water Oriented Peers, Marking Attractive Entry Point, Says Analyst

Select Energy Services Is Trading At Meaningful Discount To Water Oriented Peers, Marking Attractive Entry Point, Says Analyst

Mar 23, 2023, 2:09 PM

Exane BNP Paribas Initiates Coverage On Toast with Neutral Rating, Announces Price Target of $16

Exane BNP Paribas Initiates Coverage On Toast with Neutral Rating, Announces Price Target of $16

Exane BNP Paribas analyst Thomas Poutrieux initiates coverage on Toast (NYSE:TOST) with a Neutral rating and announces Price Target of $16.

Mar 23, 2023, 12:30 PM

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023

Mar 23, 2023, 11:00 AM

Why This Intuitive Surgical Analyst Is Bullish About 'Durable Growth'

Why This Intuitive Surgical Analyst Is Bullish About 'Durable Growth'

Intuitive Surgical Inc. (NASDAQ: ISRG) shares have been in focus for its short interest.

Mar 23, 2023, 10:18 AM

Mizuho Reinstates Neutral on Roper Techs, Announces $475 Price Target

Mizuho Reinstates Neutral on Roper Techs, Announces $475 Price Target

Mizuho analyst Brett Linzey reinstates Roper Techs (NYSE:ROP) with a Neutral and announces $475 price target.

Mar 23, 2023, 7:09 AM

William Blair Initiates Coverage On Intuitive Surgical with Outperform Rating

William Blair Initiates Coverage On Intuitive Surgical with Outperform Rating

William Blair analyst Brandon Vazquez initiates coverage on Intuitive Surgical (NASDAQ:ISRG) with a Outperform rating.

Mar 23, 2023, 7:05 AM

Berenberg Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces Price Target of $26

Berenberg Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces Price Target of $26

Berenberg analyst Zhiqiang Shu initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and announces Price Target of $26.

Mar 23, 2023, 7:03 AM

BMO Capital Initiates Coverage On Boyd Group Services with Outperform Rating, Announces Price Target of C$240

BMO Capital Initiates Coverage On Boyd Group Services with Outperform Rating, Announces Price Target of C$240

BMO Capital analyst Tamy Chen initiates coverage on Boyd Group Services (TSX:BYD) with a Outperform rating and announces Price Target of C$240.

Mar 23, 2023, 6:50 AM

BMO Capital Initiates Coverage On Disc Medicine with Outperform Rating, Announces Price Target of $40

BMO Capital Initiates Coverage On Disc Medicine with Outperform Rating, Announces Price Target of $40

BMO Capital analyst Evan Seigerman initiates coverage on Disc Medicine (NASDAQ:IRON) with a Outperform rating and announces Price Target of $40.

Mar 23, 2023, 6:49 AM

Citigroup Reinstates Sell on AMC Enter Hldgs, Announces $1.6 Price Target

Citigroup Reinstates Sell on AMC Enter Hldgs, Announces $1.6 Price Target

Citigroup analyst Jason Bazinet reinstates AMC Enter Hldgs (NYSE:AMC) with a Sell and announces $1.6 price target.

Mar 23, 2023, 6:40 AM